Page last updated: 2024-08-23

substance p and Cephalgia Syndromes

substance p has been researched along with Cephalgia Syndromes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashina, M; Bendtsen, L; Ekman, R; Jensen, R; Olesen, J	1
Austermann, K; Göbel, H; Heinze, A; Heinze-Kuhn, K	1

Reviews

1 review(s) available for substance p and Cephalgia Syndromes

Article	Year
[Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes]. Der Nervenarzt, 2001, Volume: 72, Issue:4 Topics: Analgesics, Non-Narcotic; Botulinum Toxins, Type A; Clinical Trials as Topic; Cluster Headache; Dystonic Disorders; Facial Neuralgia; Germany; Headache Disorders; Humans; Migraine Disorders; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Neuromuscular Agents; Practice Guidelines as Topic; Substance P	2001

Article

Year

[Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].

Der Nervenarzt, 2001, Volume: 72, Issue:4

Topics: Analgesics, Non-Narcotic; Botulinum Toxins, Type A; Clinical Trials as Topic; Cluster Headache; Dystonic Disorders; Facial Neuralgia; Germany; Headache Disorders; Humans; Migraine Disorders; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Neuromuscular Agents; Practice Guidelines as Topic; Substance P

2001

Other Studies

1 other study(ies) available for substance p and Cephalgia Syndromes

Article	Year
Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain, 1999, Volume: 83, Issue:3 Topics: Adult; Cerebrovascular Circulation; Female; Headache Disorders; Humans; Male; Middle Aged; Neuropeptide Y; Substance P; Tension-Type Headache; Vasoactive Intestinal Peptide	1999